These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis. Zaitsev S; Spitzer D; Murciano JC; Ding BS; Tliba S; Kowalska MA; Bdeir K; Kuo A; Stepanova V; Atkinson JP; Poncz M; Cines DB; Muzykantov VR J Pharmacol Exp Ther; 2010 Mar; 332(3):1022-31. PubMed ID: 19952305 [TBL] [Abstract][Full Text] [Related]
9. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448 [TBL] [Abstract][Full Text] [Related]